Evidence map›Paper›PMID 42884022›Full record

ArticleInternational journal of molecular sciences2026

Toward Advanced Quantitative Prediction of Missense Variant Effects.

Shaopei Ye, Selen Özkan, Aitana Díaz-Vásquez, Natàlia Padilla, Xavier de la Cruz

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shaopei YeResearch Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.
Selen ÖzkanResearch Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.ORCID 0000-0002-7398-1351
Aitana Díaz-VásquezResearch Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.ORCID 0009-0009-6248-4032
Natàlia PadillaResearch Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.
Xavier de la CruzResearch Unit in Clinical and Translational Bioinformatics, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.ORCID 0000-0002-9738-8472

Funding

Component 2 - Resource ProjectU41HG007346 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI BRENNER, STEVEN E · 2015 to 2017
$1.7M
Critical Assessment of Genome Interpretation ConferenceR13HG006650 · NHGRI · UNIVERSITY OF CALIFORNIA BERKELEY · PI BRENNER, STEVEN E · 2011 to 2018
$165k
China Scholarship Council File No. 202206310029Ministerio de Ciencia, Innovación y Universidades PID2022-142753OB-I00Ministerio de Ciencia, Innovación y Universidades TED2021-130342B-I00NHGRI NIH HHS R13 HG006650NHGRI NIH HHS U41 HG007346
6 · The paper itself

Abstract

Predicting how missense variants alter protein function is central to resolving the genotype-to-phenotype equation, a task now addressed by numerous computational predictors. The most accurate are increasingly opaque, however, limiting both their mechanistic value and their adoption in the clinic. Here we present QAFIsplit, a redesign of the Quantitative Assessment of Functional Impact framework that models variant effect in two interpretable stages: the mutation tolerance of a position, and the deviation introduced by a specific substitution. Framed as the prediction of a molecular endophenotype, QAFIsplit reaches state-of-the-art quantitative accuracy on independent deep mutational scanning benchmarks, surpassing black-box predictors such as AlphaMissense in most protein domains. Carried into clinical variant classification, it performs on par with established clinical tools without ever being trained on clinical labels, and complements meta-predictors without penalty. In the CAGI 7 community experiment, QAFI-based strategies were submitted blindly to four independent disease-gene challenges, backed by strong pre-submission clinical validation (AUC up to 0.99).

Indexed as

Computational BiologyMutation, MissenseHumansPrediction Algorithmsclinical variant interpretationensemble learningmissense variantsmolecular endophenotypemutation toleranceprotein-specific predictorstwo-step position-informed regressionvariant effect prediction

Identifiers

PMID42884022
PMCPMC13664852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.